BioLineRX (BLRX) Stock: Buy, Sell, or Hold?
BLRX - BioLineRX Ltd
$2.04
-0.02 (-1.14%)
▼
5d:
+1.49%
30d:
-19.05%
90d:
-27.58%
WAIT
LOW Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Nov 23, 2026
29d
Get Alerted When BLRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: BLRX shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: BLRX shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: BLRX is currently trading at $2.04, which is considered oversold relative to its 30-day fair value range of $2.11 to $2.48.
Technical Outlook: Technically, BLRX is in a strong downtrend. Immediate support is located at $1.95, while resistance sits at $2.34.
Market Sentiment: BLRX scores 70/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $22.00 (+978.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BLRX is in a strong downtrend. Immediate support is located at $1.95, while resistance sits at $2.34.
Market Sentiment: BLRX scores 70/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $22.00 (+978.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.11 -
$2.48
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (70/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 978.4% below Wall St target ($22.00)
- WARNING: Composite score 49/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.11 -
$2.48
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.95
Resistance Level
$2.34
Current Trend
Strong Downtrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.81
Wall Street Target
$22.00
(+978.4%)
Revenue Growth (YoY)
-3.3%
Share & Embed Analysis
Last updated: October 24, 2026 6:54 AM ET
Data refreshes hourly during market hours. Next update: 7:54 AM
Data refreshes hourly during market hours. Next update: 7:54 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BLRX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RVMD
Revolution Medicines Inc |
STRONG BUY
24 analysts |
$258 | 61 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
21 analysts |
$95 | 50 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$72 | 48 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
23 analysts |
$86 | 52 HOLD |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
18 analysts |
$36 | 43 HOLD |
